<DOC>
	<DOCNO>NCT01987076</DOCNO>
	<brief_summary>Drug reaction eosinophilia systemic symptom ( DRESS ) rare severe multiorgan adverse drug reaction occur within 2 6-8 week new drug intake . DRESS syndrome define combination clinical manifestation , cutaneous , visceral biological disturbance . Its prognosis directly link severity visceral involvement , mortality evaluate 10 % . Considering curative treatment , consensus . Until , control trial performed . Systemic steroid mainly use first intention , particular management visceral involvement , whatever severity . From clinical practice , topical steroid often use could helpful therapeutic management DRESS . We propose evaluate systemic steroid versus potent topical steroid multicentric randomize controlled trial include define moderate DRESS , ie non-inferiority potent topical steroid term remission visceral involvement Day30 superiority potent topical steroid term delay remission skin involvement .</brief_summary>
	<brief_title>Comparison Between Corticosteroid Topical Steroids DRESS</brief_title>
	<detailed_description />
	<mesh_term>Eosinophilia</mesh_term>
	<mesh_term>Drug Hypersensitivity Syndrome</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<mesh_term>Emollients</mesh_term>
	<criteria>patient age ≥ 18 year sign informed consent form DRESS diagnosis least 4 criterion , b , c , 1 . Skin rash occur least 10 day two month continuous drug intake ( within less 10 day case rechallenge ) 2 . Fever ≥ 38 ° time examination fever ≥ 38.5 ° peak last 72 hour ( amendment 2 : ANSM + CPP : 08/04/14 ) 3. least one visceral compatible : lymphadenopathy least two different site measure least 1 cm diameter transaminase &gt; 2 upper limit normal ( ULN ) alkaline phosphatise &gt; 3 ULN lung involvement define hypoxemia ( capillary oximetry ≤ 95 % ) and/or interstitial lung disease chest radiography scanner , absence lung disease myocarditis , pericarditis ( ECG clinical suspicion confirm echocardiography ) renal impairment define creatinine increase normal laboratory value associate leucocyturia &gt; 1000 / mm3 proteinuria , Na / K ratio &gt; 1 Urine Cytobacteriology ( EBCU ) sterile absence preexist renal disease ) At least one follow haematological abnormality : eosinophilia ≥ 0.7 g/l &gt; 10 % absolute lymphocytosis ≥ 5*10^9 /l presence atypical blood lymphocyte Patient moderate DRESS : define least one reach follow : pulmonary : interstitial pneumonia oxygen partial pressure arterial blood ( PaO2 ) 6075 mmHg without dyspnoea rest Hepatic : transaminase ≥ 4 ULN &lt; 15 ULN and/or PAL ≥5 ULN V factor 50 % ( amendment 2 : ANSM + CPP : 08/04/14 ) renal : acute renal failure organic sharp increase 48 hour precede inclusion 26.4 micromol/l creatinine / increase 1.5 time normal creatinine value / decrease oliguria le 0.5 ml/kg/h follow 6 hour cord : pancytopenia ( 7≤Hb≤10 gr/dl and/or 50 &lt; p &lt; 100 G/L , 0.5 &lt; PNN≤1.5G/l ) AND absence cardiac , neurological gastrointestinal ( gut , pancreas ) threaten Drug withdrawal Patient health insurance ( entitle beneficiary ) Patient accept constraint test uncontrolled sepsis unability discontinue medication ( ) due know hypersensitivity systemic topical corticosteroid hepatitis B C know , ( active HIV status know suppress amendment 5 : ANSM16/04/2015 CPP 07/04/2015 ) ( Patient already treat corticosteroid : More 48 hour Less 48 hour follow condition : Patients receive 1 mg/kg/day prednisone per o Patients receive methylprednisolone pulse 1mg/kg prednisone equivalent ( Patients receive 30 gram per day level 3 topical steroid 10 gram per day level 4 topical steroid &gt; suppress amendment 3 : ANSM 28/05/14 CPP : 10/06/14 ) ( Patient undergo immunosuppressive therapy another disease suppress amendment 5 : ANSM16/04/2015 CPP 07/04/2015 ) Participation another drug biomedical research Primitive bacterial infection , fungal parasitic Severe rosacea contindicating use corticosteroid Presence least one ulcerated lesion ( 10cm2 ) Severe dermatitis perioral contindicating use corticosteroid Severe acne contraindicate use corticosteroid Pregnant nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>DRESS</keyword>
	<keyword>Systemic steroid</keyword>
	<keyword>Topical steroid</keyword>
	<keyword>Treatment</keyword>
</DOC>